Evidence map›Paper›PMID 30088485›Full record

ArticleAnatolian journal of cardiology2018

Higher diuretic dosing within the first 72 h is predictive of longer length of stay in patients with acute heart failure.

Hirotaka Kato, Perry Fisher, Dahlia Rizk

Open access · diamondAbstract read
In one paragraph

Article in Anatolian journal of cardiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Author`s Reply.Anatolian journal of cardiology · 2019
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Hirotaka KatoDepartment of Medicine, Mount Sinai Beth Israel, Icahn School of Medicine at Mount Sinai; New York-USA. hkato@uky.edu.
Perry Fisher
Dahlia Rizk
Mount Sinai Beth Israel · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveHigh-dose diuretic strategies during the first 72 h of hospitalization have been shown to improve symptom resolution in patients with acute heart failure with decreased ejection fraction; however, they have not been shown to decrease length of stay (LOS). This study aimed to examine a possible relationship between higher diuretic dosing in the first 72 h of hospitalization and longer LOS in such patients.

methodsIn this retrospective study, we included 333 consecutive patients hospitalized for acute heart failure with decreased or preserved ejection fraction between July 2014 and June 2015 in an urban academic medical center. Multiple regression models with stepwise selection were used for data analysis. We also performed mediation analysis to assess the relationships between diuretic dose, worsening renal function (WRF) during the hospitalization, and LOS.

resultsIn the multiple regression analysis, higher diuretic dosing in the first 72 h independently predicted longer LOS [ß=0.42, 95% CI (0.27, 0.56), p<0.001] after adjustments for baseline characteristics, disease severity, and comorbidities. In the mediation analysis, higher diuretic dosing remained a significant predictor for longer LOS even after controlling for the mediator WRF [ß=0.39, 95% CI (0.26, 0.53), p<0.001]. WRF had a weak mediation effect on the relationship between higher diuretic dosing and longer LOS [indirect effect of higher diuretic dosing on longer LOS: 0.07, 95% CI (0.02, 0.14)].

conclusionHigher diuretic dosing in the first 72 h of hospitalization was an independent predictor for longer LOS.

Indexed as

Length of StayAgedCohort StudiesDiureticsDrug Administration ScheduleFemaleHeart FailureHumansMaleRegression AnalysisRenal InsufficiencyRetrospective StudiesDiuretics

Identifiers

PMID30088485
PMCPMC6237957
OpenAlexW2804868528

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.